Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Rapid generation of stable cell lines expressing high levels of erythropoietin, factor VIII, and an antihuman CD20 antibody using lentiviral vectors.

Baranyi L, Doering CB, Denning G, Gautney RE, Harris KT, Spencer HT, Roy A, Zayed H, Dropulic B.

Hum Gene Ther Methods. 2013 Aug;24(4):214-27. doi: 10.1089/hgtb.2013.002.

PMID:
23879627
2.

Lentiviral vector-mediated genetic modification of cell substrates for the manufacture of proteins and other biologics.

Baranyi L, Roy A, Embree HD, Dropulic B.

PDA J Pharm Sci Technol. 2010 Sep-Oct;64(5):379-85.

PMID:
21502041
3.

Lentiviral vector platform for production of bioengineered recombinant coagulation factor VIII.

Spencer HT, Denning G, Gautney RE, Dropulic B, Roy AJ, Baranyi L, Gangadharan B, Parker ET, Lollar P, Doering CB.

Mol Ther. 2011 Feb;19(2):302-9. doi: 10.1038/mt.2010.239. Epub 2010 Nov 16.

4.

Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles.

Szebeni J, Alving CR, Rosivall L, Bünger R, Baranyi L, Bedöcs P, Tóth M, Barenholz Y.

J Liposome Res. 2007;17(2):107-17. Review.

PMID:
17613700
5.

Inhibition of HIV-1 infection by synthetic peptides derived CCR5 fragments.

Imai M, Baranyi L, Okada N, Okada H.

Biochem Biophys Res Commun. 2007 Feb 23;353(4):851-6. Epub 2006 Dec 21.

PMID:
17210123
6.

Poly(amino acid)s: promising enzymatically degradable stealth coatings for liposomes.

Romberg B, Metselaar JM, Baranyi L, Snel CJ, Bünger R, Hennink WE, Szebeni J, Storm G.

Int J Pharm. 2007 Mar 1;331(2):186-9. Epub 2006 Nov 11.

PMID:
17145145
7.

Complement activation-related cardiac anaphylaxis in pigs: role of C5a anaphylatoxin and adenosine in liposome-induced abnormalities in ECG and heart function.

Szebeni J, Baranyi L, Sávay S, Bodó M, Milosevits J, Alving CR, Bünger R.

Am J Physiol Heart Circ Physiol. 2006 Mar;290(3):H1050-8. Epub 2005 Oct 7.

8.

Cerebrovascular involvement in liposome-induced cardiopulmonary distress in pigs.

Bodo M, Szebeni J, Baranyi L, Savay S, Pearce FJ, Alving CR, Bünger R.

J Liposome Res. 2005;15(1-2):3-14.

PMID:
16194924
9.

Changes in the intracranial rheoencephalogram at lower limit of cerebral blood flow autoregulation.

Bodo M, Pearce FJ, Baranyi L, Armonda RA.

Physiol Meas. 2005 Apr;26(2):S1-17. Epub 2005 Mar 29.

PMID:
15798222
10.

Inactivation of C5a anaphylatoxin by a peptide that is complementary to a region of C5a.

Fujita E, Farkas I, Campbell W, Baranyi L, Okada H, Okada N.

J Immunol. 2004 May 15;172(10):6382-7.

11.

The interaction of liposomes with the complement system: in vitro and in vivo assays.

Szebeni J, Baranyi L, Savay S, Milosevits J, Bodo M, Bunger R, Alving CR.

Methods Enzymol. 2003;373:136-54. No abstract available.

PMID:
14714402
12.

Complement activation during hemorrhagic shock and resuscitation in swine.

Szebeni J, Baranyi L, Savay S, Götze O, Alving CR, Bünger R, Mongan PD.

Shock. 2003 Oct;20(4):347-55.

PMID:
14501949
13.

Complement C5a receptor-mediated signaling may be involved in neurodegeneration in Alzheimer's disease.

Farkas I, Takahashi M, Fukuda A, Yamamoto N, Akatsu H, Baranyi L, Tateyama H, Yamamoto T, Okada N, Okada H.

J Immunol. 2003 Jun 1;170(11):5764-71.

14.

F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins.

Basta M, Van Goor F, Luccioli S, Billings EM, Vortmeyer AO, Baranyi L, Szebeni J, Alving CR, Carroll MC, Berkower I, Stojilkovic SS, Metcalfe DD.

Nat Med. 2003 Apr;9(4):431-8. Epub 2003 Mar 3.

PMID:
12612546
15.

Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies.

Szebeni J, Baranyi L, Savay S, Milosevits J, Bunger R, Laverman P, Metselaar JM, Storm G, Chanan-Khan A, Liebes L, Muggia FM, Cohen R, Barenholz Y, Alving CR.

J Liposome Res. 2002 Feb-May;12(1-2):165-72.

PMID:
12604051
16.

CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9.

Farkas I, Baranyi L, Ishikawa Y, Okada N, Bohata C, Budai D, Fukuda A, Imai M, Okada H.

J Physiol. 2002 Mar 1;539(Pt 2):537-45.

17.

Potentiation of liposome-induced complement activation by surface-bound albumin.

Savay S, Szebeni J, Baranyi L, Alving CR.

Biochim Biophys Acta. 2002 Feb 10;1559(1):79-86.

18.

Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction.

Szebeni J, Baranyi L, Savay S, Bodo M, Morse DS, Basta M, Stahl GL, Bünger R, Alving CR.

Am J Physiol Heart Circ Physiol. 2000 Sep;279(3):H1319-28.

19.

Heterogeneous nuclear ribonucleoprotein D0 contains transactivator and DNA-binding domains.

Tolnay M, Baranyi L, Tsokos GC.

Biochem J. 2000 May 15;348 Pt 1:151-8.

20.

C5a receptor expression by TGW neuroblastoma cells.

Farkas I, Baranyi L, Kaneko Y, Liposits Z, Yamamoto T, Okada H.

Neuroreport. 1999 Sep 29;10(14):3021-5.

PMID:
10549816
21.

Estrogen receptor immunoreactivity is present in the majority of central histaminergic neurons: evidence for a new neuroendocrine pathway associated with luteinizing hormone-releasing hormone-synthesizing neurons in rats and humans.

Fekete CS, Strutton PH, Cagampang FR, Hrabovszky E, Kalló I, Shughrue PJ, Dobó E, Mihály E, Baranyi L, Okada H, Panula P, Merchenthaler I, Coen CW, Liposits ZS.

Endocrinology. 1999 Sep;140(9):4335-41.

PMID:
10465307
22.

Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells.

Farkas I, Baranyi L, Liposits ZS, Yamamoto T, Okada H.

Neuroscience. 1998 Oct;86(3):903-11.

PMID:
9692726
23.

A neuronal C5a receptor and an associated apoptotic signal transduction pathway.

Farkas I, Baranyi L, Takahashi M, Fukuda A, Liposits Z, Yamamoto T, Okada H.

J Physiol. 1998 Mar 15;507 ( Pt 3):679-87.

24.

Endothelin (ET)-1 induced mucosal damage in the rat small intestine: role of ET(A) receptors.

Massberg S, Boros M, Leiderer R, Baranyi L, Okada H, Messmer K.

Shock. 1998 Mar;9(3):177-83.

PMID:
9525324
25.

Antisense homology box-derived peptides represent a new class of endothelin receptor inhibitors.

Baranyi L, Campbell W, Ohshima K, Fujimoto S, Boros M, Kaszaki J, Okada H.

Peptides. 1998;19(2):211-23.

PMID:
9493852
26.

Endothelin 1 induces leukocyte adhesion in submucosal venules of the rat small intestine.

Boros M, Massberg S, Baranyi L, Okada H, Messmer K.

Gastroenterology. 1998 Jan;114(1):103-14.

PMID:
9428224
27.

Endothelin-1-induced circulatory response in the rat: the role of ETA and ETB receptors.

Szalay L, Boros M, Baranyi L, Okada H, Nagy S.

Acta Chir Hung. 1997;36(1-4):340-2.

PMID:
9408395
28.

Effects of antiendothelin treatment on the early hemodynamic changes in hyperdynamic endotoxemia.

Kaszaki J, Wolfárd A, Boros M, Baranyi L, Okada H, Nagy S.

Acta Chir Hung. 1997;36(1-4):152-3.

PMID:
9408324
29.
30.

Antagonistic peptides against human anaphylatoxin C5a.

Kaneko Y, Okada N, Baranyi L, Azuma T, Okada H.

Immunology. 1995 Sep;86(1):149-54.

31.

The antisense homology box: a new motif within proteins that encodes biologically active peptides.

Baranyi L, Campbell W, Ohshima K, Fujimoto S, Boros M, Okada H.

Nat Med. 1995 Sep;1(9):894-901.

PMID:
7585214
32.

The role of a complement regulatory protein in rat mesangial glomerulonephritis.

Nishikage H, Baranyi L, Okada H, Okada N, Isobe K, Nomura A, Yoshida F, Matsuo S.

J Am Soc Nephrol. 1995 Aug;6(2):234-41.

33.

Induction of neonatal transplantation tolerance and lymphoproliferative disorders in mice: the role of F1 donor cells.

Jánossy T, Baranyi L, Vizler C, Nyirati I, Végh P.

Transplant Proc. 1995 Feb;27(1):188-90. No abstract available.

PMID:
7878968
34.

Partial characterization of a low molecular weight phagocytosis inhibitory factor obtained from human erythrocyte membranes.

Baranyi L, Baranji K, Yoshida T, Okada N, Okada H.

Immunobiology. 1994 Dec;192(1-2):94-105.

PMID:
7750990
35.

In vivo effects of monoclonal antibodies that functionally inhibit complement regulatory proteins in rats.

Matsuo S, Ichida S, Takizawa H, Okada N, Baranyi L, Iguchi A, Morgan BP, Okada H.

J Exp Med. 1994 Nov 1;180(5):1619-27.

36.

Membrane-bound complement regulatory activity is decreased on vaccinia virus-infected cells.

Baranyi L, Okada N, Baranji K, Takizawa H, Okada H.

Clin Exp Immunol. 1994 Oct;98(1):134-9.

38.

Cell-surface bound complement regulatory activity is necessary for the in vivo survival of KDH-8 rat hepatoma.

Baranyi L, Baranji K, Takizawa H, Okada N, Okada H.

Immunology. 1994 Aug;82(4):522-8.

39.

Autoimmunity, hyporeactivity to T cell mitogens and lymphoproliferative disorders following neonatal induction of transplantation tolerance in mice.

Jánossy T, Baranyi L, Knulst AC, Vizler C, Benner R, Kelényi G, Végh P.

Eur J Immunol. 1993 Nov;23(11):3011-20.

PMID:
8223878
40.
41.

Lethal systemic graft-vs-host disease in neonatally tolerant, but not in F1 hybrid mice.

Vizler C, Jánossy T, Baranyi L, Végh P.

Cell Immunol. 1993 Feb;146(2):431-7.

PMID:
8174181
42.
43.

Induction of transplantation tolerance and development of lymphomas in mice: lack of interdependence.

Végh P, Baranyi L, Jánossy T.

Cell Immunol. 1990 Aug;129(1):56-66.

PMID:
2364442

Supplemental Content

Loading ...
Support Center